BackCOSCIENS Biopharma Overview

COSCIENS Biopharma Operating Income

Operating Income for AEZS.

Quarterly Operating Income

$-3755000.00
↑ 31.52% YoY

As of Jun 30, 2024

Annual Operating Income (TTM)

$-20960481.00
↑ 41.76% YoY

Trailing 12 months ending Jun 30, 2024

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin